ClinicalTrials.gov
public full text
Public Domain
A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants
QRL-101-03 is a multiple ascending dose (MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of QRL-101 in healthy participants. QRL-101-03 is a follow-on study to QRL-101-01, an ongoing Phase 1, single ascending dose study to determine the safety, tolerability, and PK profile of QRL-101 after a single dose (ClinicalTrials.gov ID: NCT05667779).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects#911437
- Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults#1008963
- Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide#1152869
- A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects#813763
- The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors#1008070
Record · ID 850545
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive